Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

50.38
-0.1900-0.38%
Post-market: 50.380.00000.00%19:30 EDT
Volume:56.14K
Turnover:2.82M
Market Cap:1.71B
PE:10.31
High:50.75
Open:50.75
Low:49.88
Close:50.57
52wk High:53.25
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.75
T/O Rate:0.20%
Dividend:3.06
Dividend Rate:6.06%
EPS(TTM):4.89
EPS(LYR):2.11
ROE:27.21%
ROA:5.25%
PB:2.55
PE(LYR):23.88

Loading ...

How Investors May Respond To CVS (CVS) Expanding GLP-1 Support And Virtual Chronic Care Services

Simply Wall St.
·
Jun 23

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

Global GP acquires $431,050 of Global Partners common units

Reuters
·
Jun 23

CVS Health Expands GLP-1 Support for Patients

Dow Jones
·
Jun 22

CVS Health announces comprehensive approach to GLP-1 support

TIPRANKS
·
Jun 22

Swiss Voters Reject Population Cap Initiative, Highlighting Europe's Enduring Immigration Dilemma

Deep News
·
Jun 19

GLP J-REIT Secures 26 Billion Yen Refinancing

MT Newswires Live
·
Jun 19

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

GlobeNewswire
·
Jun 18

GLP J-REIT refinances ¥26.2bn debt, extends loan maturities to 2032

TIPRANKS
·
Jun 18

Global GP LLC acquires $466,950 of Global Partners common units

Reuters
·
Jun 17

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

GlobeNewswire
·
Jun 16

Global Partners (GLP) Stock Valuation After Earnings Beat And Supportive Fuel Market Conditions

Simply Wall St.
·
Jun 14

Nyse Order Imbalance 6605.0 Shares on Buy Side

THOMSON REUTERS
·
Jun 13

Global GP LLC reports $498,050 purchase of Global Partners common units

Reuters
·
Jun 12

Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market

TIPRANKS
·
Jun 12

Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports

TIPRANKS
·
Jun 11

How Investors May Respond To Innovent Biologics (SEHK:1801) Advancing Oral And Extended-Interval GLP-1 Candidates

Simply Wall St.
·
Jun 11

Cracker Barrel CEO: GLP-1s Haven't Affected Our Business -- Market Talk

Dow Jones
·
Jun 10

Market Chatter: Ares Management in Talks to Acquire GLP Data Centers

MT Newswires Live
·
Jun 09

AstraZeneca's GLP-1 Pill Clears Early Hurdle in Diabetes, Obesity Tests -- WSJ

Dow Jones
·
Jun 09